Merck Agrees To Buy Rare Disease Specialist Acceleron Pharma For $11.5 Billon - NewsBreak Home > Business > Article
3 years ago By Martin — Merck & Co. (MRK) - Get Merck & Co., Inc. (MRK) Report agreed to buy Acceleron Pharma Inc. (XLRN) - Get Acceleron Pharma Inc Report Thursday in a deal that
#merck #buyrarediseasespecialistacceleronpharma #billon